10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Atyr Pharma Inc (ATYR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 4,883,197 | $17,677,171 | 0.03% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,683,000 | $6,092,460 | -1% | 0.04% |
| 3. | Alyeska Investment Group Anand Parekh | 1,278,441 | $4,627,956 | -27% | 0.01% |
| 4. | Logos Capital Arsani William | 1,000,000 | $3,620,000 | -50% | 0.42% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 1,000,000 | $3,620,000 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 3,750 | 9,750 | 2025-03-17 | Filing | ||
| $1.93 | 52,300 | 413,023 | 2024-07-24 | Filing | ||
| $1.82 | 6,648 | 360,723 | 2024-07-23 | Filing | ||
| $1.74 | 41,052 | 354,075 | 2024-07-22 | Filing | ||
| $1.86 | 5,000 | 22,267 | 2024-06-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 1,254 | 31,763 | 2025-02-04 | Filing | ||
| $3.78 | 899 | 26,555 | 2025-02-04 | Filing | ||
| $1.69 | 1,590 | Officer | 20,821 | 2024-02-06 | Filing | |
| $2.36 | 1,566 | Officer | 15,460 | 2023-02-06 | Filing | |
| $4.34 | 2,500 | Director | 108,083 | 2021-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,666,600 | $53,093,092 | 0.11% | |
| 2. | 12,097,429 | $43,792,693 | 0% | |
| 3. | 3,604,927 | $13,049,836 | 0% | |
| 4. | 2,460,833 | $8,908,215 | 2.42% | |
| 5. | 1,525,113 | $5,520,910 | 0% |
News See All
aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Billionaire Hedge Funds
